Concepedia

Author

John H. Sampson

Duke Medical CenterORCID

Also Known As

Crane, Lawrence R., H. Friedman, J H Sampson, J H. Sampson, J. H. Sampson, J. Herndon, J. Sampson, J.H. Sampson, JOHN SAMPSON, James H. Sampson

722

Publications

36.4K

Citations

100

H-Index

185

Concepts

All Affiliations

Duke Medical CenterDuke University HospitalDuke UniversityDana-Farber Cancer InstituteUniversity of California, San Francisco
JH

About

John H. Sampson is an author at Duke Medical Center specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

48

102

9.3K

2

Health Sciences

16

21

1.4K

3

Engineering

8

8

388

4

Natural Sciences

3

3

463

5

Language Studies

1

1

23

John H. Sampson

×

222

Publications

27.6K

Citations

86

H-Index

YearCitations

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh, Annick Desjardins, James E. Herndon,

Journal of Clinical Oncology

2007

1.4K

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon, Alba A. Brandes, Antonio Omuro,

JAMA Oncology

2020

1.4K

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran,

The Lancet Oncology

2017

1.1K

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

John H. Sampson, Amy B. Heimberger, Gary E. Archer,

Journal of Clinical Oncology

2010

793

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Annick Desjardins, Matthias Gromeier, James E. Herndon,

New England Journal of Medicine

2018

768

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich, David A. Reardon, Terry Peery,

Journal of Clinical Oncology

2003

726

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama,

Nature Medicine

2018

641

Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma

Peter E. Fecci, Duane A. Mitchell, John F. Whitesides,

Cancer Research

2006

609

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma

John H. Sampson, James Carter, Allan H. Friedman,

Journal of neurosurgery

1998

555

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Duane A. Mitchell, Kristen A. Batich, Michael D. Gunn,

Nature

2015

510

Page 1